Synthesis and Bioactivity of Thiazolethioacetamides as Potential Metallo-β-Lactamase Inhibitors
Open Access
- 26 February 2020
- journal article
- research article
- Published by MDPI AG in Antibiotics
- Vol. 9 (3) , 99
Abstract
Metallo-β-lactamase (MβLs) mediated antibiotic resistance seriously threatens the treatment of bacterial diseases. Recently, we found that thioacetamides can be a potential MβL inhibitor skeleton. In order to improve the information of the skeleton, twelve new thiazolethioacetamides were designed by modifying the aromatic substituent. Biological activity assays identify the thiazolethioacetamides can inhibit ImiS with IC50 values of 0.17 to 0.70 μM. For two of them, the IC50 values against VIM-2 were 2.2 and 19.2 μM, which is lower than in our previous report. Eight of the thiazolethioacetamides are able to restore antibacterial activity of cefazolin against E.coli-ImiS by 2–4 fold. An analysis of the structure–activity relation and molecule docking show that the style and position of electron withdrawing groups in aromatic substituents play a crucial role in the inhibitory activity of thiazolethioacetamides. These results indicate that thiazolethioacetamides can serve as a potential skeleton of MβL inhibitors.Keywords
Funding Information
- Natural Science Foundation of Shaanxi Province (2018JQ2070)
- the Scientific Research Plan Project by Educational Department of Shaanxi Province (18JK0250)
- the Natural Science Foundation of Shangluo University (16SKY021)
- the science and technology development fund of Zhang Shengyong academician (18YSZX002)
This publication has 20 references indexed in Scilit:
- Past and Present Perspectives on β-LactamasesAntimicrobial Agents and Chemotherapy, 2018
- An update on β-lactamase inhibitor discovery and developmentDrug Resistance Updates, 2018
- Antibacterial and β‐Lactamase Inhibitory Activity of Monocyclic β‐LactamsMedicinal Research Reviews, 2017
- Membrane anchoring stabilizes and favors secretion of New Delhi metallo-β-lactamaseNature Chemical Biology, 2016
- Multidrug evolutionary strategies to reverse antibiotic resistanceScience, 2016
- Discovery of Novel Inhibitor Scaffolds against the Metallo-β-lactamase VIM-2 by Surface Plasmon Resonance (SPR) Based Fragment ScreeningJournal of Medicinal Chemistry, 2015
- Updated Functional Classification of β-LactamasesAntimicrobial Agents and Chemotherapy, 2010
- Three Decades of β-Lactamase InhibitorsClinical Microbiology Reviews, 2010
- Metallo-β-lactamases (classification, activity, genetic organization, structure, zinc coordination) and their superfamilyBiochemical Pharmacology, 2007
- Bacterial Resistance to β-Lactam Antibiotics: Compelling Opportunism, Compelling OpportunityChemical Reviews, 2005